Those Most in Need Least Likely to Get Newer Diabetes Medications

Racial and socioeconomic disparities may be impeding access to newer diabetes medications, including DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors, among US patients. Medscape Medical News

Read More

Leave a Reply

%d bloggers like this: